CYCN cyclerion.com: Market Capitalization

Public company logo of Cyclerion (CYCN)

This daily price chart for Cyclerion Therapeutics (CYCN), where the market capitalization stands at 0.01, demonstrates the activity of an issuer developing orphan drugs that require strict temperature control during transport. Current structural shifts within Cyclerion Therapeutics (CYCN) are already priced in, while growth drivers for sGC stimulators have yet to materialize. The business relies on the modulation of brain pathways for neuronal rehabilitation in specific CNS pathologies.

CYCN Cyclerion Therapeutics Inc.: Market Capitalization in the range 07/04/2022 - 09/09/2026

CYCN (Cyclerion): analytical breakdowns and indicator data

Fundamental company analysis:CYCN (Cyclerion Therapeutics, Inc.)
Product sample of Cyclerion Therapeutics Inc.

The scale of Cyclerion Therapeutics (CYCN) operations in neuropharmacology determines its market value. This metric is calculated as the product of the current share price and the total number of outstanding securities. It reflects the aggregate investor valuation of the potential for neuron recovery in rare disorders. This price action captures the market's reaction to the company's scientific achievements. Analyzing the issuer's market capitalization allows for an objective assessment of the business's real value.

Key competitors

Market Capitalization BIIB (Biogen Idec)|Neurocrine Biosciences Inc - Market Value|regencellbioscience.com - Market Capitalization|Market Capitalization axsome.com AXSM|ACAD: Market Capitalization|Market Value Xenon Pharmaceuticals Inc. (XENE)|Market Value Viking Therapeutics|Market Capitalization SUPN (Supernus Pharma)|Market Capitalization CPRX|DNLI - Market Value|harmonybiosciences.com - Market Valuation|Market Capitalization Biohaven Ltd BHVN|AMLX - Market Value|Market Value TRVI (Trevi Corp)|Praxis Precision Medicines Inc (PRAX) - Market Value|Market Value Anavex Life Sciences (AVXL)|CBLL (CeriBell Inc) - Market Capitalization|Prothena Corporation - Market Valuation|Market Value Alector (ALEC)|Annexon Biosciences Inc. - Market Capitalization|Market Capitalization OMER (Omeros)|Market Capitalization neurogene.com NGNE|AC Immune S.A. - Market Capitalization|VYGR - Market Capitalization|neumoratx.com (NMRA) - Market Value|Market Value Scilex Holding Company (SCLX)|TVGN (Tevogen Bio Holdings Inc.) - Market Capitalization|ACOG: Market Value|Market Capitalization CGTX|Market Capitalization Inhibikase Therapeutics Inc (IKT)|Cassava - Market Valuation|assertiotx.com (ASRT) - Market Value|COYA - Market Value|Market Value VTGN (VistaGen Therapeutics, Inc.)|OVID: Market Capitalization|Acumen Pharmaceuticals Inc. (ABOS) - Market Capitalization|Market Value CervoMed Inc.|ATHE: Market Value|Market Value Clene (CLNN)|PEPG: Market Valuation|Market Value Jupiter Neurosciences, Inc. JUNS|Market Capitalization Relmada Therapeutics Inc RLMD|ANVS - Market Value|GRCE - Market Capitalization|AIFF: Market Capitalization|KLTO - Market Capitalization|NRSN (NeuroSense Therapeutics, Ltd.) - Market Capitalization|Market Capitalization Reviva Pharmaceuticals Holdings|Market Capitalization MTVA|Market Capitalization NeurAxis Inc|Helius Medical Technologies - Market Valuation|Market Capitalization Passage Bio, Inc. PASG|NEUP: Market Valuation|Minerva Neurosciences, Inc. (NERV) - Market Valuation|ATHA (Athira Pharma) - Market Valuation|Market Capitalization ADXN|Market Value Alzamend Neuro, Inc.|Protagenic Therapeutics (PTIX) - Market Capitalization|Market Value pasitheaclinics.com (KTTA)|CRGT (Cortigent Inc) - Market Value|Market Capitalization ATXI (Avenue Therapeutics Inc)|Market Value BCLI|Cara Therapeutics Inc - Market Capitalization|Chromocell Therapeutics (CHRO) - Market Valuation|ELYM (Eliem Therapeutics Inc.) - Market Valuation|ITCI - Market Capitalization|Market Value Longboard Pharma|Market Capitalization MRNS (Marinus Pharma)|Market Value NKGen Biotech Inc (NKGN)|NRBO - Market Value|Market Capitalization SAGE (Sage Therapeutics Inc)|Synaptogenix Inc. (SNPX) - Market Value|TRVN: Market Valuation|Market Capitalization vigilneuro.com VIGL|WENA (Anew Medical Inc.) - Market Valuation|Market Valuation Cerevel Therapeutics